Zydus Lifesciences Share Price
NSE: ZYDUSLIFE|BSE: 532321|Pharmaceuticals50% Hold
₹1,047.85
+₹14.05 (1.36%) As on 18 Sep, 2025 | 15:46 ISTZydus Lifesciences Stock Performance
Market cap  ₹1,04,025 Crs | Open ₹1,035.00 | Prev. Close ₹1,033.80 |
Circuit range ₹1,137.15 - ₹930.45 | Day range ₹1,025.50 - ₹1,049.95 | Year range ₹795.00 - ₹1,088.85 |
Volume 9,77,193 | Avg. traded ₹1,037.38 | Revenue (12m) ₹23,608 Crs |
About Zydus Lifesciences
Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.
As of last trading day, Zydus Lifesciences opened at ₹1,035.00 and last traded at ₹1,047.85, showing a rise of 14.05 points (1.36%) compared to the previous close of ₹1,033.80. During the session, the stock touched a high of ₹1,049.95 and a low of ₹1,025.50. The company's market capitalization now stands at ₹1,04,025 Crs, with a P/E ratio of 15.4 and a dividend yield of 1.24%.
19 September 2025 – Zydus Lifesciences Share Price Update
As of last trading day, Zydus Lifesciences opened at ₹1,035.00 and last traded at ₹1,047.85, showing a rise of 14.05 points (1.36%) compared to the previous close of ₹1,033.80. During the session, the stock touched a high of ₹1,049.95 and a low of ₹1,025.50. The company's market capitalization now stands at ₹1,04,025 Crs, with a P/E ratio of 15.4 and a dividend yield of 1.24%.Zydus Lifesciences Share Price Chart
₹1,047.85+₹14.05 (1.36%)
Please wait...
Zydus Lifesciences Key Indicators
P/E ratio 15.43 | P/B ratio 4.2 | ROE 31.29% |
ROCE 30.47% | Dividend yield 1.24% | Debt/Equity ratio 0.39 |
EPS 57.39 |
Investment Checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst Ratings:
Hold31%
Hold
50%
Sell
19%
This analysis is based on the reviews of 26 experts in the last 7 days
Zydus Lifesciences Financial Ratios
Operating profit margin55.78% | Net profit margin38.2% |
ROE31.29% | ROA19.38% |
ROCE30.47% |
Quick ratio1.7 | Current ratio1.76 |
Interest coverage17.05 | Asset turnover0.6 |
Debt to Equity0.39 |
P/E ratio15.43 | P/B ratio4.2 |
EV / EBITDA11.54 | |
Dividend yield1.24% |
Zydus Lifesciences Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-25 | ₹23,511.00 | ₹6,026.70 | ₹4,614.80 |
Mar-24 | ₹19,831.50 | ₹4,808.90 | ₹3,854.40 |
Mar-23 | ₹17,424.00 | ₹2,589.70 | ₹1,997.30 |
Mar-22 | ₹15,334.60 | ₹2,838.10 | ₹4,572.10 |
Zydus Lifesciences Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-25 | ₹-8,372.3 | ||
Mar-24 | ₹-1,475.2 | ₹-1778.80 | |
Mar-23 | ₹-4400.40 | ||
Mar-22 | ₹-1,000.3 | ₹-868.30 |
Zydus Lifesciences Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-25 | ₹37,201.70 | ₹10,843.30 |
Mar-24 | ₹29,280.80 | ₹7,179.20 |
Mar-23 | ₹25,756.40 | ₹6,068.10 |
Mar-22 | ₹27,795.40 | ₹8,741.60 |
Zydus Lifesciences Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
04-Sep-25 | ₹1,014.50 | ₹1,011.95 | |
03-Sep-25 | ₹1,004.00 | ₹1,008.20 | |
02-Sep-25 | ₹991.05 | ₹996.10 | |
01-Sep-25 | ₹988.00 | ₹991.05 | |
29-Aug-25 | ₹984.30 | ₹981.05 | |
28-Aug-25 | ₹987.85 | ₹978.60 | -0.94% |
26-Aug-25 | ₹1,015.00 | ₹987.85 | -3.45% |
25-Aug-25 | ₹992.05 | ₹1,023.15 |
Zydus Lifesciences Corporate Actions
Dividend • ₹11/share
Ex date 25 Jul 2025
Dividend • ₹3/share
Ex date 26 Jul 2024
Zydus Lifesciences Futures & Options
| Expiry dates | Current price | Change % |
|---|---|---|
ZYDUSLIFE 1100 CE 30 SEP 25 | ₹4.90 | |
ZYDUSLIFE 1040 CE 30 SEP 25 | ₹24.60 | |
ZYDUSLIFE 1050 CE 30 SEP 25 | ₹19.40 | |
ZYDUSLIFE 1060 CE 30 SEP 25 | ₹15.00 |
View all
Stocks Similar to Zydus Lifesciences
Stock Name | Price | Change % |
|---|---|---|
| Abbott India | ₹30,890.00 | -₹80.00 (-0.26%) |
| Alkem Laboratories | ₹5,479.50 | +₹7.00 (0.13%) |
| Aurobindo Pharma | ₹1,128.90 | +₹33.20 (3.03%) |
| Biocon | ₹368.40 | +₹14.05 (3.97%) |
| Cipla | ₹1,578.20 | +₹18.60 (1.19%) |
| Gland Pharma | ₹2,016.50 | +₹29.60 (1.49%) |
| Lupin | ₹2,046.60 | +₹15.40 (0.76%) |
| Piramal Enterprises | ₹1,177.90 | +₹11.00 (0.94%) |
| Torrent Pharmaceuticals | ₹3,567.40 | +₹19.10 (0.54%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| HDFC Bank Share Price | ₹976.90 | +₹10.40 (1.08%) |
| Infosys Share Price | ₹1,540.60 | +₹18.20 (1.20%) |
| ITC Share Price | ₹411.55 | +₹2.25 (0.55%) |
| ITC HOTELS LIMITED Share Price | ₹241.43 | -₹0.77 (-0.32%) |
| JIO FIN SERVICES LTD Share Price | ₹317.35 | +₹1.50 (0.47%) |
| Reliance Share Price | ₹1,415.00 | +₹1.20 (0.08%) |
| Tata Motors Share Price | ₹711.20 | -₹7.95 (-1.11%) |
| Tata Power Share Price | ₹393.10 | -₹1.55 (-0.39%) |
| Tata Steel Share Price | ₹172.03 | +₹0.67 (0.39%) |
| Wipro Share Price | ₹256.93 | +₹2.78 (1.09%) |
Zydus Lifesciences News
Upstox
NIFTY50, SENSEX extend gains in afternoon session; L&T, NCC, Godfrey Phillips, among buzzing stocks
Upstox
Zydus Lifesciences trades lower despite launching two generic drugs for pets; check details
Upstox
Zydus Lifesciences shares in focus, after four observations from USFDA
Upstox
Zydus Lifesciences' stock declines despite subsidiary inking exclusive licensing deal with Synthon; details here
Upstox
Stocks to Watch, September 5: Aptus Value, Zydus Lifesciences, Varun Beverages, RIL, Swiggy, NTPC, cement, auto stocks
Upstox
Zydus Lifescience arm signs exclusive licensing pact with Synthon for Ozanimod capsules in the US market
Upstox
Zydus Lifesciences shares climb over 4% as net profit rises 3% YoY to ₹1,467 crore in Q1; revenue up 5.9%
Moneycontrol
Zydus Life Consolidated March 2025 Net Sales at Rs 6,527.90 crore
Moneycontrol
Gainers & Losers: Top stocks that moved the most on June 19
Moneycontrol
Zydus Life shares in focus as USFDA issues 2 observations at Ahmedabad
Zydus Lifesciences Share Price FAQs
What is the share price of Zydus Lifesciences today?
Zydus Lifesciences share price is ₹ 1,047.85 as on Sep, 2025 | 15:46 IST.
What are the high & low stock price of Zydus Lifesciences today?
Zydus Lifesciences stock price hit a high of ₹ 1,049.95 and low of ₹ 1,025.50 as on Sep, 2025 | 15:46 IST.
What is the market cap of Zydus Lifesciences?
The market cap of Zydus Lifesciences is ₹ 1,04,024.50 Crores as on Sep, 2025 | 15:46 IST.
What are the the 52-week high and low share prices of Zydus Lifesciences stock on the NSE?
52-week high stock Price of Zydus Lifesciences is ₹ 1,088.85 and Low Price is ₹ 795.00 as on Sep, 2025 | 15:46 IST.
What are the stock symbols of Zydus Lifesciences?
The stock symbol of Zydus Lifesciences is NSE: ZYDUSLIFE on the NSE, BSE: 532321 on the BSE, and the ISIN is INE010B01027.
Can I buy Zydus Lifesciences shares on Holidays?
No, shares of Zydus Lifesciences or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Zydus Lifesciences shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
How to buy Zydus Lifesciences shares?
To buy Zydus Lifesciences shares,open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order
What is the PE and PB ratio of Zydus Lifesciences?
The PE and PB ratio of Zydus Lifesciences is 15.43 and 4.2 respectively, as on Sep, 2025 | 15:46 IST.
What are the returns on Zydus Lifesciences shares?
The historical returns for Zydus Lifesciences shares are -6.94 for 1 year, 186.13 for 3 year and 162.59 for 5 year.